Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Efi Benmeir - SVP Finance & CFO International Markets - Teva Pharmaceutical Industries Ltd. | LinkedIn
Teva Pharmaceutical Industries Ltd (TEVA) Price & News - Google Finance
Teva Announces New Org Structure, Leadership Changes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Chen Zisman, PhD - Senior Director Finance - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Shivangi Singh - Manager business finance - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceutical Industries (NYSE:TEVA) - Stock Price, News & Analysis - Simply Wall St
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva workers threaten to blow up Jerusalem factory in protest over layoffs | The Times of Israel
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo Finance
Zach (Tzahi) Davidi - Sr. Finance director - Teva Pharmaceuticals | LinkedIn
Teva Reports Third Quarter 2021 Financial Results | Business Wire
Teva- Pharmaceutical Industries Ltd. - ADR (TEVA) | Finance
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceutical Industries Ltd (TEVA) Price & News - Google Finance
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha
